The effect of optimal medical therapy on 1-year mortality after acute myocardial infarction

Abstract

OMT over 1 year was associated with a significantly lower mortality of patients with acute myocardial infarction in clinical practice. However OMT is provided to less than half of eligible patients leaving room for substantial improvement.

References

Page 1

	Year	Citations
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial The Lancet Lipid DisorderCardiovascular DiseaseHealth PolicyHyperlipidemiaDyslipidemia	2002	7K
Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes Stephen D. Wiviott, Eugene Braunwald, Carolyn H. McCabe, New England Journal of Medicine	2007	6.7K
ACC/AHA Guidelines for the Management of Patients With Unstable Angina and Non–ST-Segment Elevation Myocardial Infarction: Executive Summary and Recommendations Eugene Braunwald, Elliott M. Antman, John W. Beasley, Circulation	2000	4.5K
Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE) Bertram Pitt, Robert Segal, Felipe A Martinez, The Lancet Heart FailureCardiorenal SyndromesCardiovascular DiseaseGeriatricsLosartan Versus Captopril	1997	1.7K
Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE) Keith A.A. Fox, Omar Dabbous, Robert J. Goldberg, BMJ	2006	1.6K
Contribution of trends in survival and coronar y-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA Project populations Hugh Tunstall‐Pedoe, Kari Kuulasmaa, Markku Mähönen, The Lancet Epidemiological TrendCardiovascular EpidemiologyCardiovascular DiseaseGlobal Health10-Year Results	1999	1.4K
ACC/AHA Guideline Update for the Management of Patients With Unstable Angina and Non–ST-Segment Elevation Myocardial Infarction—2002: Summary Article Eugene Braunwald, Elliott M. Antman, John W. Beasley, Circulation Acc/aha Guideline UpdatePercutaneous Coronary InterventionCardiovascular DiseaseUnstable AnginaCardiac Care	2002	846
Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): randomised trial The Lancet Percutaneous Coronary InterventionThrombosisSt-segment ElevationCardiovascular DiseaseCoronary Artery Disease	2006	656
Impact of Medication Therapy Discontinuation on Mortality After Myocardial Infarction P. Michael Ho, John A. Spertus, Frederick A. Masoudi, Archives of Internal Medicine	2006	632
Pexelizumab for Acute ST-Elevation Myocardial Infarction in Patients Undergoing Primary Percutaneous Coronary Intervention JAMA	2007	434

Page 1